Group Effect in Full Replicate Design [RSABE / ABEL]

posted by GM – India, 2018-09-12 13:23 (743 d 15:14 ago) – Posting: # 19275
Views: 4,418

» » » What do you mean by “checked”? Have group – together with some nested terms – as part of the model (only report the MSEs, p-values) or do you additionally want to base any decision on it? That’s not a good idea, since power might be compromised and the Type I Error inflated (see this presentation).
» »
» » Sorry for poor english.
»
» No worries. Mine is hardly better. But please answer my question.

We don't want to take any decisions on the basis of model terms.

Our thought is, we need to check group effect for both ABE and RSABE also.

If this correct, how the model is to be designed for RSABE?

Thank you in advance.

Best Regards,
GM

Complete thread:

Activity
 Admin contact
21,074 posts in 4,394 threads, 1,468 registered users;
online 2 (0 registered, 2 guests [including 1 identified bots]).
Forum time: Friday 04:37 CEST (Europe/Vienna)

If you think it’s simple,
then you have misunderstood the problem.    Bjarne Stroustrup

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5